Latest News

: Why the FDA didn’t grant an approval to Lilly’s Alzheimer’s drug

42 views0
By
Share

The regulator wants to see clinical data from at least 100 patients who have taken donanemab for a year 

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0
Previous
Next

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Latest News